Stockscreener 앱 받기
32.00
4.21%
1.1539
전일 마감가:
$30.85
열려 있는:
$31.29
하루 거래량:
9.33M
Relative Volume:
0.64
시가총액:
$6.97B
수익:
$1.24B
순이익/손실:
$101.26M
주가수익비율:
-188.26
EPS:
-0.17
순현금흐름:
$149.62M
1주 성능:
+4.79%
1개월 성능:
+57.91%
6개월 성능:
+56.91%
1년 성능:
+264.10%
1일 변동 폭
$30.77
$33.93
1주일 범위
$29.80
$35.02
52주 변동 폭
$8.09
$35.02
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
31.99 | 6.97B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
177.27 | 423.13B | 83.91B | 14.32B | 15.85B | 5.80 |
|
UL
Unilever Plc Adr
|
59.38 | 147.84B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
93.95 | 77.22B | 20.11B | 2.87B | 3.40B | 3.49 |
|
KMB
Kimberly Clark Corp
|
137.65 | 46.80B | 20.10B | 2.61B | 2.90B | 7.71 |
|
KVUE
Kenvue Inc
|
23.68 | 46.51B | 15.46B | 1.06B | 1.40B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Where Hims & Hers Health Stands With Analysts - Benzinga
Hims and Hers shares up 70% in November, with Q3 revenue exceeding estimates - Investing.com
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio? - Benzinga
Hims & Hers Health, Inc. (NYSE:HIMS) Position Boosted by Verition Fund Management LLC - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Sells 29,642 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Bridgewater Associates LP Boosts Position in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Algert Global LLC Cuts Position in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Comparing Hims vs. Roman 2024: What to Know About These Men’s Health Services - Healthline
Hims & Hers Health (NYSE:HIMS) Stock Quotes, Forecast and News Summary - Benzinga
Hims & Hers Health Inc (HIMS) Shares Up 5.8% on Nov 29 - GuruFocus.com
Hims & Hers: Driving Growth In Wellness (NYSE:HIMS) - Seeking Alpha
Hims & Hers Shares Jump as Trump FDA Pick Seen as Major Ally - MSN
Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus.com
Why Hims & Hers Stock Jumped on Massive FDA News - AOL
90,756 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Purchased by Tybourne Capital Management HK Ltd. - MarketBeat
FORA Capital LLC Invests $1.41 Million in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Intech Investment Management LLC Acquires Shares of 57,774 Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by Victory Capital Management Inc. - MarketBeat
Hims & Hers up 18% amid optimism for compounders with Makary FDA pick - MSN
Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity - Benzinga
Hims & Hers health chief commercial officer sells $458k in stock - Investing.com India
Hims & Hers Health (HIMS) Reaches New High Amid FDA Nomination Speculation - GuruFocus.com
Blueshift Asset Management LLC Buys 218,804 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health's chief legal officer sells $70,055 in stock - Investing.com India
130,017 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Bought by Massachusetts Financial Services Co. MA - MarketBeat
Hims & Hers CFO sells $3.02 million in stock - Investing.com
Why Hims & Hers Stock Jumped on Massive FDA News - The Motley Fool
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 44% Share Price Surge - Simply Wall St
Hims & Hers Health Inc (HIMS) Stock Price Up 14.53% on Nov 25 - GuruFocus.com
What's Going On With Hims & Hers Health Stock Monday? - Benzinga
Hims & Hers Shares Jump as Trump’s FDA Pick Seen as Major Ally - Bloomberg
Hims & Hers surges: Analysts say it's well-positioned under Trump - Yahoo Finance
Hims & Hers (HIMS) Stock Surges Amid Potential FDA Leadership Ch - GuruFocus.com
HIMS Stock Soars to All-Time High, Reaching $30.45 - Investing.com India
Hims & Hers shares jump as Trump’s FDA pick seen as major ally - Modern Healthcare
Hims & Hers Health gain on potential FDA leadership ties - Investing.com
Hims & Hers Health gain on potential FDA leadership ties By Investing.com - Investing.com Australia
BofA reiterates underperform rating on HIMS shares amid FDA leadership change - Investing.com
DRW Securities LLC Buys Shares of 109,504 Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Penserra Capital Management LLC Sells 91,424 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims and Hers stock plummets 8% after CEO says he is ‘eager’ to hire anti-Israel protesters - MSN
Him & Hers Health Stock Doubled Options Bulls' Money - Schaeffers Research
Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio? - Benzinga
29,986 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Purchased by Alpha DNA Investment Management LLC - MarketBeat
HIMS (Hims & Hers Health) Cash From Other Investing Activit - GuruFocus.com
Noteworthy Friday Option Activity: HIMS, AMBA, VZ - Nasdaq
Bulls: Bet on a Rebound for This Telehealth Stock - Schaeffers Research
Hims & Hers New Growth Category Is a Huge Surprise - Nasdaq
Hims & Hers Add Bars & Shakes for GLP-1 Users - Athletech News
The FDA Can’t Decide Whether Zepbound Is in Shortage. Hims & Hers Stock Jumps. - Barron's
Weight Wellness Nutrition Supplements - Trend Hunter
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.49%
0.68%
자본화:
|
볼륨(24시간):